Suppr超能文献

侵袭性转移性滤泡型变异型甲状腺癌伴 BRAF K601E 和 BCORL1 突变 1 例报告。

Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations.

机构信息

Internal Medicine, Harvard Medical School, Boston, Massachusetts, USA

Department of Endocrinology, Diabetes, and Metabolism, Femwell Health Group, Miami Beach, Florida, USA.

出版信息

BMJ Case Rep. 2020 Jun 30;13(6):e234208. doi: 10.1136/bcr-2019-234208.

Abstract

BCL6 corepressor like-1 (BCORL1) mutation has rarely been described in thyroid cancer or in association with BRAF mutations in any malignancy. However, we report a 49-year-old woman who had aggressive follicular variant papillary thyroid carcinoma (FV-PTC) with both the BRAF K601E and BCORL1 mutations. The patient underwent a total thyroidectomy for a 3.6 cm right thyroid nodule and a smaller lesion in the left lobe in 2007; both were FV-PTCs with no lymphovascular invasion or metastases. In 2015, a positron emission tomography-CT scan showed a small defect in the left posterior lateral fifth rib with mild increased hypermetabolic activity with standardised uptake value of 3.9 and another lesion in the right hip at the junction of the femoral neck and trochanter. Tumour biopsy and genetic analysis revealed an uncommon BRAF K601E and a rare BCORL1 mutation. While rare, we report a case of aggressive FV-PTC with both the BRAF K601E and BCORL1 mutations.

摘要

BCL6 核心抑制因子样蛋白 1(BCORL1)突变在甲状腺癌中很少被描述,也很少与任何恶性肿瘤中的 BRAF 突变相关。然而,我们报告了一例 49 岁女性患有侵袭性滤泡状变异型甲状腺乳头状癌(FV-PTC),同时存在 BRAF K601E 和 BCORL1 突变。患者于 2007 年因 3.6cm 右侧甲状腺结节和左侧较小病变接受了全甲状腺切除术;两者均为 FV-PTC,无血管淋巴管侵犯或转移。2015 年,正电子发射断层扫描-CT 扫描显示左侧后外侧第五肋骨有一小处缺损,伴有轻度增高的代谢活性,标准摄取值为 3.9,右侧髋关节股骨颈和转子交界处也有另一处病变。肿瘤活检和基因分析显示存在罕见的 BRAF K601E 和罕见的 BCORL1 突变。虽然罕见,但我们报告了一例同时存在 BRAF K601E 和 BCORL1 突变的侵袭性 FV-PTC 病例。

相似文献

2
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
Thyroid. 2016 Feb;26(2):242-7. doi: 10.1089/thy.2015.0227. Epub 2015 Dec 17.
3
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.
Thyroid. 2011 Dec;21(12):1393-6. doi: 10.1089/thy.2011.0120.
6
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.
7
Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Clin Endocrinol (Oxf). 2017 Jul;87(1):73-79. doi: 10.1111/cen.13335. Epub 2017 Apr 18.
9
BRAF Mutation in a Follicular Thyroid Adenoma: A Case Report.
Int J Surg Pathol. 2017 Jun;25(4):348-351. doi: 10.1177/1066896916688083. Epub 2017 Jan 23.

本文引用的文献

1
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3.
2
BRAF Mutation in a Follicular Thyroid Adenoma: A Case Report.
Int J Surg Pathol. 2017 Jun;25(4):348-351. doi: 10.1177/1066896916688083. Epub 2017 Jan 23.
4
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.
J Clin Endocrinol Metab. 2016 Nov;101(11):4413-4420. doi: 10.1210/jc.2016-1775. Epub 2016 Aug 29.
5
Single thyroid tumour showing multiple differentiated morphological patterns and intramorphological molecular genetic heterogeneity.
J Clin Pathol. 2017 Feb;70(2):116-119. doi: 10.1136/jclinpath-2016-203821. Epub 2016 Jul 7.
6
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer.
J Transl Med. 2016 Jul 7;14(1):204. doi: 10.1186/s12967-016-0958-x.
7
Identification of Novel Oncogenic Mutations in Thyroid Cancer.
J Am Coll Surg. 2016 Jun;222(6):1036-1043.e2. doi: 10.1016/j.jamcollsurg.2015.12.047. Epub 2016 Jan 14.
9
BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.
Int J Endocrinol. 2015;2015:138734. doi: 10.1155/2015/138734. Epub 2015 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验